**Specifications Table**TableSubject areaPsychologyMore specific subject areaEnvironmental healthType of dataTablesHow data was acquiredSurveyData formatAnalyzedExperimental factorsRestricted to children with environmental chemical biomonitoring dataExperimental featuresApplied survey weightsData source locationCanadaData accessibilityData are within this article

**Value of the data**•Cross-sectional analysis of associations between child levels of BPA, phthalates and lead with indicators of adverse child behavior, controlling for wide set of covariates.•Generates exploratory data useful for examination in prospective cohort studies.•Could be compared with similar data from US NHANES for further insight.

1. Data {#s0005}
=======

Tables of results of simple weighted regression analysis of important covariates and weighted multiple logistic regression analysis for chemicals examined. Child behavioral outcomes considered were reported learning disability, ADD/ADHD and taking psychotropic medications, as well as Strengths and Difficulties Questionnaire scores for hyperactivity/inattention, emotional symptoms and total difficulties.

2. Experimental design, materials and methods {#s0010}
=============================================

The Canadian Health Measures Survey (CHMS) was designed to collect key information on the health of Canadians using direct physical measurements, collection of blood and urine and household and clinic interviews [@bib2], [@bib3]. The target population for Cycle 1 were individuals between 6 and 79 years of age living in privately occupied dwellings, representing 97% of Canadians. This dataset was restricted to children and adolescents 6--19 years of age (*n*=2097). Information on child behavior, demographic, socioeconomic and lifestyle factors was collected by a questionnaire administered to the parent or guardian of children 6--11 years of age or directly to the child 12 years and older.

Blood was analysed for lead, while urine was analysed for BPA and phthalate metabolites. Creatinine was measured to adjust for urine dilution differences between spot urine samples. Chemical lab measures below the limit of detection were imputed as half the limit of detection.

For children 6--19 years of age, outcomes examined were reports of self-, or in the case of children 6--11 years, parent-reported learning disability (any, ADD or ADHD) and whether any medications used to treat behavioral disorders were taken in the past month. Respondents reported medications by Drug Identification Numbers (<http://www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/fs-fi/dinfs_fd-eng.php>) which were coded to Anatomical Therapeutic Chemical (ATC) codes (<http://www.whocc.no/atc_ddd_index/>). One of the co-authors (KB), a clinical child psychiatrist, provided a table of medications potentially used for treating behavioral disorders in children ([see Supplemental Material, Table S1](#s0030){ref-type="fn"} [@bib1]).

For children 6--17 years of age, borderline and abnormal scores from the Strengths and Difficulties Questionnaire (SDQ) ([www.sdqinfo.com](http://www.sdqinfo.com){#ir0015}) were grouped together and compared with children with normal scores for the outcomes emotional symptoms, hyperactivity/inattention, and the total difficulties scores.

Initially, for each outcome of interest, weighted univariate models were considered for each contaminant. Subsequently, potential risk factors were evaluated. Covariates identified through reviews of the literature included child׳s age, body mass index, number of hours slept per night, gender, highest level of household education (secondary school or less vs. at least some postsecondary studies), income adequacy (low/lower middle vs. upper middle/higher income), whether the child fasted prior to specimen collection, and ETS exposure in the home. For children 6--11 years of age only, additional covariates were available and considered: prenatal smoking, birth any time prior to due date, admission to a special neonatal unit or an intensive care unit prior to leaving hospital, and breast feeding (less than 3 months vs. three months or longer), as well as number of days in a neonatal unit, birth weight, and mother׳s age at birth.

Since the CHMS employed a complex, multistage survey design, survey weights were used in statistical modeling to account for the unequal probabilities of selection. Due to the complex sampling scheme of the CHMS Cycle 1 survey, direct calculation of standard errors and confidence intervals were not possible. To that end, Statistics Canada [@bib3] provided bootstrap weights in order to calculate standard errors, confidence intervals and coefficients of variation for each estimate using the bootstrap method.

Weighted simple logistic regression modelling was done for each of the identified covariates and the outcomes ([Table A1](#t0005){ref-type="table"}, [Table A2](#t0010){ref-type="table"}, [Table A3](#t0015){ref-type="table"}, [Table A4](#t0020){ref-type="table"}, [Table A5](#t0025){ref-type="table"}, [Table A6](#t0030){ref-type="table"}, [Table A7](#t0035){ref-type="table"}). Weighted multiple logistic regression models were then run considering the environmental contaminants and other important covariates identified in the simple regressions ([Table B1](#t0040){ref-type="table"}, [Table B2](#t0045){ref-type="table"}, [Table B3](#t0050){ref-type="table"}, [Table B4](#t0055){ref-type="table"}, [Table B5](#t0060){ref-type="table"}, [Table B6](#t0065){ref-type="table"}). For urinary chemicals, creatinine concentration was included in all the multiple regression models as a separate independent variable [@bib4].

In order to determine which of the available variables resulted in the best fit, a stepwise procedure was implemented. The natural-log of the contaminant concentrations was used since the contaminants were lognormally distributed based on the Anderson--Darling test. However since the complex survey design limited the number of degrees of freedom to 11, a stepwise selection method was used to determine which covariates were most significant to improve the model fit. The contaminant and creatinine concentrations were retained in the model, and then other covariates were sequentially added to the model based on the smallest *p*-value (i.e. the most significant variables). This approach facilitated the evaluation of demographic variables one-at-a-time with respect to their p-value, conditional on other variables already in the model. This approach also served to examine the effect of multicollinearity, which could inflate standard errors and provide misleading results. For some models, after examining the main effects, sufficient degrees of freedom were available to evaluate an interaction term between highly significant covariates. Furthermore, to compare models, the model with significant terms and with the lowest value of the Akaike Information Criterion (AIC) was selected. Goodness of fit was assessed using the Hosmer--Lemeshow test. Odds ratios were calculated from weighted multiple logistic regression models for a 1-unit increase in the log of the contaminant concentration ([Table C1](#t0070){ref-type="table"}, [Table C2](#t0075){ref-type="table"}).

The software package SAS (Statistical Analysis System) Enterprise Guide 4.2 was used for statistical analysis. For regression modeling, the software programs BOOTVAR and SUDAAN were used along with the bootstrap weights, in order to correctly calculate such estimates. Finally, for all statistical analysis performed, an inference was deemed significant at *α*=5% unless otherwise indicated.

A. Simple logistic regressions -- weighted results for children 6--19 years of age, CHMS cycle 1 {#s0015}
================================================================================================

See Table A1Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome reported ADD (6--19 years of age).Table A1Outcome: ADD**Factor (reference category)*****n*****EstimateStandard error*P*-valueOdds ratio (OR)95% CI for Odds ratio**Child׳s age20870.140.060.051.151.001.33BMI -- measured20810.000.040.971.000.911.09Gender (males)20871.040.580.102.830.7910.06Education (secondary school or less)20310.730.520.182.070.676.45Income (low/lower middle)19271.040.480.052.830.998.09Prenatal smoking (yes)10380.270.710.711.310.247.10Born any time before due date (yes)10470.950.610.182.60.5412.39Special neonatal unit care (yes)10471.240.40.013.471.408.57No. of days in neonatal unit10660.010.110.91.010.81.29Hours of sleep per night20870.170.160.310.840.591.21Birth weight1039−0.000.000.211.001.001.00Breast feeding (3 months or longer)1037−0.770.670.280.460.102.03Mother׳s age at birth1065−0.030.060.60.970.841.11Anyone smoking at home (yes)20821.480.490.014.381.4912.88Fasted (yes)2087−0.140.470.770.870.302.46Table A2Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome reported ADHD (6--19 years of age).Table A2Outcome: ADHD**Factor (reference category)*****n*****EstimateStandard error*P*-valueOdds ratio (OR)95% CI for odds ratio**Child׳s age20870.0000.050.951.000.901.1BMI -- measured2081−0.050.040.160.950.871.03Gender (males)20871.310.480.023.691.2710.71Education (secondary school or less)2031−0.110.660.870.900.203.96Income (low/lower middle)19270.960.450.062.620.967.13Prenatal smoking10381.220.350.0063.391.557.40Born any time before due date10470.620.390.1401.870.794.39Special neonatal unit care1039NRNRNRNRNRNRNo. of days in neonatal unit1066NRNRNRNRNRNRHours of sleep per night2087−0.030.130.830.970.731.29Birth weight10390.000.000.781.001.001.00Breast feeding (3 months or longer)1037−0.480.790.550.620.113.48Mother׳s age at birth1065−0.110.070.140.900.771.04Anyone smoking at home (Yes)20820.670.50.211.950.655.83Fasted (yes)20870.380.330.261.470.723.00[^1]Table A3Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome reported learning disability (6--19 years of age).Table A3Outcome: Learning disability**Factor (reference category)*****n*****EstimateStandard error*P*-valueOdds ratio (OR)95% CI for odds ratio**Child׳s age20940.040.030.331.040.961.12BMI -- measured20880.010.020.61.010.971.05Gender (males)20940.850.310.022.341.194.60Education (secondary school or less)20380.260.260.331.300.742.3Income (low/lower middle)19340.920.240.0032.501.474.27Prenatal smoking (yes)10430.710.350.072.040.944.42Born any time before due date (yes)10520.280.260.301.320.752.35Special neonatal unit care (yes)10720.820.350.042.271.064.86No. of days in neonatal unit10710.010.020.661.010.971.05Hours of sleep per night2094−0.10.10.350.910.731.13Birth weight1044000.861.001.001.00Breast feeding (3 months or longer)1042−0.250.330.460.780.381.6Mother׳s age at birth1070−0.060.040.130.940.861.02Anyone smoking at home (yes)20890.840.210.0022.321.483.64Fasted (yes)20940.10.200.631.100.711.72Table A4Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome reported psychotropic medicines taken in past month (6 -- 19 years of age).Table A4Outcome: Medicine taken**Factor (reference category)*****n*****EstimateStandard error*P*-valueOdds ratio (OR)95% CI for odds ratio**Child׳s age20960.000.030.991.000.941.06BMI -- measured20900.050.040.251.050.961.15Gender (males)20960.790.260.012.211.253.93Education (secondary school or less)20410.670.590.281.950.537.14Income (low/lower middle)19360.300.570.611.350.394.70Prenatal smoking (yes)10430.870.60.172.400.649.01Born any time before due date (yes)10530.760.210.0042.141.343.42Special neonatal unit care (yes)1073−0.070.490.890.930.322.77No. of days in neonatal unit10720.000.050.9410.891.11Hours of sleep per night2096−0.20.060.0080.820.720.94Birth weight10450.000.000.031.001.001.00Breast feeding (3 months or longer)1043−0.980.590.130.380.101.38Mother׳s age at birth1071−0.040.050.460.960.861.07Anyone smoking at home (yes)20910.670.610.301.950.517.55Fasted (yes)20960.950.210.011.871.172.98Table A5Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome SDQ emotional symptoms (ages 6--17 years).Table A5Outcome: SDQ emotional symptoms**Factor (reference category)*****n*****EstimateStandard error*P*-valueOdds ratio (OR)95% CI for odds ratio**Child׳s age17170.020.020.481.020.971.07BMI -- measured17150.060.030.051.061.001.13Gender (males)1717−0.440.170.030.650.440.95Education (Secondary school or less)16760.650.290.041.921.033.61Income (low/lower middle)16490.340.260.221.400.792.49Prenatal smoking (yes)10450.340.510.531.400.454.34Born any time before due date (yes)10540.470.230.071.600.962.67Special neonatal unit care (yes)10740.470.370.231.600.713.57No. of days in neonatal unit10730.02−0.040.981.000.961.04Hours of sleep per night1717−0.20.070.020.820.700.95Birth weight1046000.121.001.001.00Breast feeding (3 months or longer)1044−0.290.230.230.750.461.23Mother׳s age at birth107200.010.911.000.971.03Anyone smoking at home (yes)17130.240.260.381.270.712.27Fasted (yes)17170.50.180.021.651.102.47Table A6Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome SDQ hyperactivity/inattention (ages 6--17 years).Table A6Outcome: SDQ hyperactivity/inattention**Factor (reference category)*****n*****EstimateStandard error*P*-valueOdds ratio (OR)95% CI for odds ratio**Child׳s age1717−0.050.040.150.950.881.02BMI -- measured17150.000.020.841.000.961.04Gender (males)17170.510.140.0041.661.222.24Education (secondary school or less)16760.520.260.081.680.942.99Income (low/lower middle)16490.520.200.021.681.092.58Prenatal smoking (yes)10450.90.280.0092.471.324.61Born any time before due date (yes)1054−0.070.140.630.930.691.27Special neonatal unit care (yes)1074−0.10.360.790.900.412.02No. of days in neonatal unit10730.020.950.951.000.961.04Hours of sleep per night1717−0.040.080.680.970.811.16Birth weight1046000.881.001.001.00Breast feeding (3 months or longer)1044−0.410.180.040.660.450.98Mother׳s age at birth1072−0.020.020.290.980.941.02Anyone smoking at home (yes)17130.780.310.032.181.114.31Fasted (yes)17170.020.220.921.020.631.67Table A7Weighted simple logistic regression estimates for covariates from CHMS Cycle 1 with outcome SDQ total difficulties (ages 6--17 years).Table A7Outcome: SDQ total difficulties**Factor (reference category)*****n*****EstimateStandard error*P*-valueOdds ratio (OR)95% CI for odds ratio**Child׳s age1717−0.050.050.310.950.861.06BMI -- measured17150.040.030.301.040.971.11Gender (males)17170.260.240.291.300.772.19Education (secondary school or less)16760.420.540.451.520.465.02Income (low/lower middle)16490.690.300.041.991.023.89Prenatal smoking (yes)10451.150.430.023.171.248.09Born any time before due date (yes)10540.320.200.131.380.902.13Special neonatal unit care (yes)10740.350.240.181.420.832.42No. of days in neonatal unit1073−0.000.010.851.000.981.02Hours of sleep per night1717−0.090.120.480.920.701.20Birth weight10460.000.000.651.001.001.00Breast feeding (3 months or longer)1044−0.450.170.020.640.430.93Mother׳s age at birth1072−0.030.030.350.970.911.04Anyone smoking at home (yes)17130.770.330.042.161.044.50Fasted (yes)17170.370.280.211.450.782.69[Table A1](#t0005){ref-type="table"}, [Table A2](#t0010){ref-type="table"}, [Table A3](#t0015){ref-type="table"}, [Table A4](#t0020){ref-type="table"}, [Table A5](#t0025){ref-type="table"}, [Table A6](#t0030){ref-type="table"}, [Table A7](#t0035){ref-type="table"}

B. Multiple logistic regressions -- weighted results for all children {#s0020}
=====================================================================

See Table B1Weighted multiple logistic regression estimates from CHMS Cycle 1 with reported ADD/ADHD (6--19 years of age).Table B1**ExposureCovariateEstimateSE*P*-valueOdds ratio95% CI for odds ratio**BPAIntercept−2.960.720.0018ln(creatinine)−0.280.180.16260.760.511.14ln(BPA)0.260.180.60891.290.861.94Smoking at home (yes)0.840.340.03122.321.104.90Child׳s age0.050.050.3131Income (low/low-middle)0.670.310.05331.950.993.83Gender (males)−0.170.630.7911*Gender*: *males vs*. *females*[a](#tblB1fna){ref-type="table-fn"}*3.061.675.61*BMI−0.100.030.01520.910.840.98ln(lead)0.830.260.00872.281.294.04Gender\*child׳s age0.100.050.0593*Age*: *males1.161.061.27Age*: *females1.050.961.15*              Blood leadIntercept−4.130.40\<0.0001ln(lead)0.870.270.00802.391.324.32Smoking at home (yes)0.930.350.02152.541.185.46Gender (males)1.080.320.00642.931.455.94Income (low/low-middle)0.760.380.06742.150.944.91              MBPIntercept−2.670.680.0029ln(creatinine)0.350.250.18691.420.822.48ln(MBP)−0.210.180.26370.810.551.20Income (low/lower middle)−0.240.810.7697*Income*: *low/low*-*middle vs*. *middle/upper (males*)*3.611.3010.03*Gender (males)0.440.410.3151*Income*: *low*/*low-middle vs. middle-upper* (*females*)*0.780.106.15*ln(Lead)1.000.270.00462.711.475.00Income\*gender1.530.830.0971*Males vs. females* (*low*/*low*-*middle*)*7.111.1244.92Males vs*. *females* (*middle*/*upper*)*1.550.693.46*              MBzPIntercept−4.040.870.0007ln(creatinine)−0.280.240.27070.760.451.29ln(MBzP)0.390.210.09121.480.932.36Child׳s age0.050.060.4167Income (low/low-middle)0.790.440.10132.210.835.84Gender (males)−1.070.670.1390*Males vs*. *females*[a](#tblB1fna){ref-type="table-fn"}*2.811.455.45*ln(lead)0.840.250.00662.331.334.06BMI−0.080.040.06850.920.841.01Child׳s age\*gender0.170.060.0135*Child׳s age*: *males1.241.071.44Child׳s age*: *females1.050.941.18*              MCPPIntercept−3.810.46\<0.0001ln(creatinine)0.220.230.35781.250.752.07ln(MCPP)−0.020.140.89770.980.721.34Income (low/low-middle)0.900.530.11872.450.767.84Gender (males)1.040.380.01872.831.236.50ln(lead)0.940.270.00532.561.414.66              MEHHPIntercept−2.660.840.0090ln(creatinine)0.430.280.15171.530.832.82ln(MEHHP)−0.340.240.17710.710.421.20Income (low/low-middle)0.890.530.11802.440.777.78Gender (males)1.010.370.02032.741.216.21ln(lead)0.990.280.00502.701.455.05              MEHPIntercept−3.630.53\<0.0001ln(creatinine)0.290.250.27491.340.772.33ln(MEHP)−0.160.140.28300.850.621.17Income (low/low-Middle)0.920.530.10702.510.797.99Gender (males)1.030.380.02102.811.216.56ln(lead)0.970.280.00482.641.444.85              MEOHPIntercept−2.820.820.0054ln(creatinine)0.420.290.18081.520.802.89ln(MEOHP)−0.340.250.19350.710.411.22Income (low/low-middle)0.890.530.11732.440.777.78Gender (males)0.990.370.02082.701.206.08ln(lead)0.990.280.00512.701.445.05              MEPIntercept−2.700.990.0193ln(creatinine)0.480.400.25871.610.673.88ln(MEP)−0.290.230.22990.750.451.24Income (low/low-middle)0.930.520.10312.520.807.95Gender (males)0.970.360.02182.641.195.90ln(lead)0.960.280.00592.611.404.86[^2]Table B2Weighted multiple logistic regression estimates from CHMS Cycle 1 with report of a learning disability (6--19 years of age).Table B2**ExposureCovariateEstimateSE*P*-valueOdds ratio95% CI for odds ratio**BPAIntercept−3.030.28\<0.0001ln(creatinine)0.100.110.36231.110.871.41ln(BPA)0.090.170.60891.090.761.57Smoking at home (yes)0.500.190.02521.651.082.53Gender (males)0.570.260.04671.781.013.12ln(lead)1.100.360.0116Income (low/lower-middle)0.660.350.0869*Income*: *low/low*-*middle vs*. *middle*/*upper*[a](#tblB2fna){ref-type="table-fn"}*2.441.314.52*ln(lead)\*Income−1.270.450.0163*ln*(*lead*): *low/low*-*middle0.850.381.86ln*(*Lead*): *middle*/*upper3.001.476.12*              Blood leadIntercept−3.070.26\<0.0001ln(lead)1.020.350.0138Smoking at home (yes)0.570.180.00881.761.192.61Income (low/low-middle)0.640.330.0791*Income*: *low/low-middle vs. middle/upper*[a](#tblB2fna){ref-type="table-fn"}*2.381.344.24*Gender (males)0.680.290.03811.981.053.75ln(lead) \* income−1.230.450.0195*ln*(*lead*): *low*/*low*-*middle0.810.371.81ln*(*lead*): *middle*/*upper2.781.405.51*              MBPIntercept−1.380.720.0825ln(creatinine)0.480.140.00641.611.182.21ln(MBP)−0.230.160.17970.790.561.13Gender (males)0.660.290.04221.931.033.62Income (low/lower Middle)−0.780.400.07900.460.191.11ln(lead)0.850.280.01022.351.284.31              MBzPIntercept−2.960.600.0005ln(creatinine)0.150.150.33961.160.841.61ln(MBzP)0.220.160.20171.240.871.77Gender (males)0.700.300.03832.021.053.89Income (low/low-Middle)−0.700.410.11840.500.201.23ln(lead)0.800.280.01442.231.214.08              MCPPIntercept−2.420.430.0002ln(creatinine)0.330.150.05561.380.991.93ln(MCPP)0.170.160.3235Gender (males)0.970.320.0115*Males vs. females*[b](#tblB2fnb){ref-type="table-fn"}*2.081.153.76*Income (low/low-Middle)−0.740.410.09510.480.191.16ln(lead)0.830.270.01112.291.264.17ln(MCPP) \* gender−0.280.090.0114*ln*(*MCPP*): *males0.890.651.21ln*(*MCPP*): *females1.180.861.62*              MEHHPIntercept−1.320.970.1986ln(creatinine)0.480.210.04151.621.022.55ln(MEHHP)−0.270.250.28990.760.441.31Gender (males)0.660.280.03641.941.053.56Income (low/low-Middle)−0.720.390.09470.490.201.16ln(lead)0.860.270.00832.371.314.27              MEHPIntercept−2.030.380.0003ln(creatinine)0.390.160.03441.481.032.11ln(MEHP)−0.170.160.32830.850.591.21Gender (males)0.680.290.03661.981.053.71Income (low/low-Middle)−0.750.400.08820.470.191.14ln(lead)0.850.270.00962.341.294.26              MEOHPIntercept−1.450.920.1421ln(creatinine)0.470.220.05101.601.002.58ln(MEOHP)−0.270.260.31970.760.431.35Gender (males)0.650.280.03771.921.053.51Income (low/low-Middle)−0.720.400.09460.490.201.16ln(lead)0.860.270.00852.371.314.28              MEPIntercept−1.290.690.0874ln(creatinine)0.530.240.04671.701.012.88ln(MEP)−0.240.170.18680.790.541.15Gender (males)0.630.280.04511.881.023.49Income (low/low-middle)−0.760.400.08370.470.191.13ln(lead)0.840.290.01422.311.234.34[^3][^4]Table B3Weighted multiple logistic regression estimates from CHMS Cycle 1 with reported psychotropic medicine taken in past month for behavioral problems (6--19 years of age).Table B3**ExposureCovariateEstimateSE*P*-valueOdds ratio95% CI for odds ratio**BPAIntercept−2.530.440.0001ln(creatinine)−0.170.170.33450.840.581.22ln(BPA)−0.030.150.8625Hours slept−0.200.070.01190.820.700.95Gender (males)0.540.280.0826*Males vs*. *females*[a](#tblB3fna){ref-type="table-fn"}*2.161.283.62*Fasted (yes)0.690.250.01951.981.143.45ln(BPA)\*gender0.650.210.0093*ln*(*BPA*): *males1.871.242.83ln*(*BPA*): *females0.970.721.31*              Blood leadIntercept−2.190.470.0007ln(lead)1.430.400.0042Gender (males)0.730.330.04852.081.014.29Fasted (yes)0.510.300.1206*Fasted* (*yes vs. no*)[b](#tblB3fnb){ref-type="table-fn"}*2.251.194.26*ln(lead)\*fasted−1.620.550.0135*ln*(*lead*): *fasted0.830.342.02ln*(*lead*): *no fasting4.201.929.17*                Hours slept−0.220.070.00950.800.680.94              MBPIntercept−2.430.790.0103ln(creatinine)0.180.260.50671.190.682.11ln(MBP)−0.020.220.93690.980.601.60Hours Slept−0.200.050.00100.820.740.90Gender (males)0.920.310.01382.511.265.01Fasted (yes)0.710.230.01082.041.223.40              MBzPIntercept−1.620.630.0270ln(creatinine)0.050.230.83061.050.631.76ln(MBzP)−0.250.190.2147Hours slept−0.230.060.00180.800.700.90Gender (males)−1.140.490.0415*Males vs. females*[c](#tblB3fnc){ref-type="table-fn"}*2.451.314.58*Fasted (yes)0.770.250.01102.161.243.77ln(MBzP)\*gender0.680.150.0010*ln*(*MBzP*): *males1.541.072.23ln*(*MBzP*): *females0.780.541.13*              MCPPIntercept−2.900.510.0001ln(creatinine)−0.320.290.2894ln(MCPP)0.510.190.02021.661.102.51Hours slept−0.230.050.00080.790.710.89Gender (males)0.930.330.0181*Males vs*. *Females*[d](#tblB3fnd){ref-type="table-fn"}*2.421.274.61*Fasted (yes)1.340.300.0010*Fasted (yes vs. no)*[e](#tblB3fne){ref-type="table-fn"}*2.451.503.99*ln(creatinine)\*gender0.590.290.0640ln(MCPP)\*fasted−0.510.150.0051*ln(MCPP)*: *fasted1.000.691.44ln*(*MCPP*): *no fasting1.661.152.40*              MEHHPIntercept−2.801.050.0221ln(creatinine)−0.280.360.4473ln(MEHHP)0.080.300.78641.090.562.10Hours slept−0.200.050.00140.810.730.91Gender (males)0.920.320.0159*Males vs*. *females*[d](#tblB3fnd){ref-type="table-fn"}*2.391.284.46*Fasted (yes)0.730.220.00672.081.283.37ln(creatinine)\*gender0.620.290.0518              MEHPIntercept−2.550.660.0027ln(creatinine)−0.220.380.5757ln(MEHP)0.010.320.97951.010.502.05Hours slept−0.200.050.00120.820.740.91Gender (males)0.910.330.0184*Males vs*. *females*[d](#tblB3fnd){ref-type="table-fn"}*2.371.264.48*Fasted (yes)0.710.230.00992.031.233.34ln(creatinine)\*gender0.610.300.0671              MEOHPIntercept−2.770.920.0120ln(creatinine)−0.290.360.4405ln(MEOHP)0.090.300.77021.090.562.13Hours slept−0.210.050.00140.810.730.91Gender (males)0.920.320.0147*Males vs. females*[d](#tblB3fnd){ref-type="table-fn"}*2.401.294.46*Fasted (yes)0.730.220.00632.081.293.36ln(creatinine)\*gender0.630.280.0486              MEPIntercept−3.360.820.0018ln(creatinine)−0.350.310.2853ln(MEP)0.160.130.24711.170.881.54Hours slept−0.180.050.00450.840.750.93Gender (males)0.960.340.0168*Males vs*. *females*[d](#tblB3fnd){ref-type="table-fn"}*2.501.304.80*Fasted (yes)0.710.230.00972.031.233.33ln(creatinine)\*gender0.610.300.0664[^5][^6][^7][^8][^9]Table B4Weighted multiple logistic regression estimates from CHMS Cycle 1 with outcome SDQ Emotional Symptoms (ages 6--17 years).Table B4**ExposureCovariateEstimateSE*P*-valueOdds ratio95% CI for odds ratio**BPAIntercept1.501.120.2088ln(creatinine)0.200.130.14161.230.921.63ln(BPA)0.070.050.16821.070.971.19Hours slept−0.270.100.01830.770.620.95Gender (males)−0.410.110.00320.660.520.84Fasted (yes)0.490.210.04241.631.022.61Child׳s age−0.080.030.04150.920.861.00            Blood leadIntercept−0.220.750.7758ln(lead)0.080.210.72081.080.681.71Gender (males)−0.400.180.05080.670.451.00Hours slept−0.190.080.03700.830.700.99Fasted (yes)0.530.250.05531.700.992.95Education (secondary school or less)0.570.230.03241.781.062.97            MBPIntercept−0.990.630.1426ln(creatinine)0.350.170.06141.420.982.04ln(MBP)−0.140.160.40870.870.611.24Gender (males)−0.320.160.06310.720.511.02            MBzPIntercept1.921.060.0962ln(creatinine)0.380.170.04311.471.012.13ln(MBzP)−0.110.080.20490.900.751.07Gender (males)−0.290.150.07920.750.531.04Hours slept−0.240.100.03860.790.630.99Child׳s age−0.080.040.05030.920.841.00            MCPPIntercept1.561.110.1875ln(creatinine)0.340.180.08331.410.952.08ln(MCPP)−0.060.080.46430.940.781.13Gender (males)−0.290.160.08900.750.531.05Hours slept−0.230.100.04470.790.630.99Child׳s age−0.080.040.06370.920.851.01            MEHHPIntercept−1.690.430.0023ln(creatinine)0.200.100.06541.220.981.52ln(MEHHP)0.050.110.63881.050.831.33Gender (males)−0.300.150.07640.740.531.04            MEHPIntercept−1.490.16\<0.0001ln(creatinine)0.250.100.03361.281.021.60ln(MEHP)−0.020.090.86020.980.801.21Gender (males)−0.300.150.07550.740.531.04            MEOHPIntercept−1.680.380.0011ln(creatinine)0.200.100.07501.220.981.53ln(MEOHP)0.060.110.61451.060.831.34Gender (males)−0.300.160.07960.740.531.04            MEPIntercept−1.560.270.0001ln(creatinine)0.220.120.08401.250.961.62ln(MEP)0.010.070.86311.010.871.18Gender (males)−0.300.150.07160.740.531.03Table B5Weighted multiple logistic regression estimates from CHMS Cycle 1 with outcome SDQ Hyperactivity/Inattention (ages 6--17 years).Table B5**ExposureCovariateEstimateSE*P*-valueOdds ratio95% CI for odds ratio**BPAIntercept−1.960.14\<0.0001ln(creatinine)−0.080.120.51840.920.711.20ln(BPA)0.270.050.0003Smoking at home (yes)0.910.240.0031*Smoking at home* (*yes vs*. *no*)[a](#tblB5fna){ref-type="table-fn"}*1.961.233.11*ln(lead)0.940.160.00012.561.793.65ln(BPA)\*smoking at home−0.670.210.0079*ln(BPA)*: *smoking at home0.670.461.00ln(BPA)*: *no smoking at home1.311.181.46*              Blood leadIntercept−2.060.20\<0.0001ln(lead)0.850.180.00052.331.593.43Gender (males)0.360.180.07051.440.962.14Smoking at home (Yes)0.740.360.06202.100.964.62                  MBPIntercept−2.400.730.00700.090.020.45ln(creatinine)0.050.200.78791.060.691.62ln(MBP)0.160.210.4626*Smoking at home* (*yes vs. no*)[b](#tblB5fnb){ref-type="table-fn"}*1.590.942.71*ln(lead)0.960.200.00062.611.674.07Smoking at home (yes)2.480.920.0204ln(MBP)\*smoking at home−0.580.280.0628*ln*(*MBP*): *smoking at home0.660.391.12ln*(*MBP*): *no smoking at home1.170.781.76*              MBzPIntercept−2.250.30\<0.0001ln(creatinine)−0.020.110.82880.980.771.23ln(MBzP)0.160.090.10471.170.961.43ln(lead)0.970.190.00032.631.743.99              MCPPIntercept−1.970.22\<0.0001ln(creatinine)−0.050.130.71450.950.711.27ln(MCPP)0.200.100.08211.220.971.53ln(lead)0.950.200.00062.581.674.00              MEHHPIntercept−1.890.320.0001ln(creatinine)0.070.120.60301.070.811.40ln(MEHHP)0.040.080.59761.040.881.23ln(lead)0.980.200.00042.681.744.12              MEHPIntercept−1.680.17\<0.0001ln(creatinine)0.120.120.33751.130.861.49ln(MEHP)−0.050.110.64400.950.751.20ln(lead)0.990.200.00042.701.734.20              MEOHPIntercept−1.790.310.0001ln(creatinine)0.080.120.51501.090.831.43ln(MEOHP)0.020.080.84721.020.851.21ln(lead)0.990.200.00042.681.734.15              MEPIntercept−1.500.330.0008ln(creatinine)0.150.120.21011.170.901.51ln(MEP)−0.070.060.32070.940.821.08ln(lead)0.990.200.00052.691.724.20[^10][^11]Table B6Weighted multiple logistic regression estimates from CHMS Cycle 1 with outcome SDQ Total Difficulties (ages 6--17 years).Table B6**ExposureCovariateEstimateSE*P*-valueOdds ratio95% CI for odds ratio**BPAIntercept−2.360.18\<0.0001ln(creatinine)−0.180.150.26860.840.601.17ln(BPA)0.130.080.11181.140.961.36Smoking at home (yes)0.570.280.06801.760.953.27ln(lead)0.810.250.00802.241.293.87            Blood leadIntercept−2.250.16\<0.0001ln(lead)0.770.220.00492.161.333.51Smoking at home (yes)0.740.380.07392.100.924.81            MBPIntercept−2.450.950.0250ln(creatinine)−0.040.260.89610.970.541.72ln(MBP)0.090.250.73531.090.621.91ln(lead)0.840.220.00292.321.433.76            MBzPIntercept−3.150.39\<0.0001ln(creatinine)−0.200.190.32130.820.541.25ln(MBzP)0.310.110.01891.371.061.76ln(lead)0.820.240.00562.261.343.82            MCPPIntercept−2.190.29\<0.0001ln(creatinine)−0.020.250.94270.980.571.69ln(MCPP)0.060.200.76911.060.681.66ln(lead)0.850.230.00342.331.413.84            MEHHPIntercept−1.720.770.0457ln(creatinine)0.110.280.70791.110.602.05ln(MEHHP)−0.110.180.54510.890.601.33ln(lead)0.870.250.00512.381.384.10            MEHPIntercept−1.920.310.0001ln(creatinine)0.120.240.63141.130.661.93ln(MEHP)−0.160.180.39100.860.581.26ln(lead)0.880.240.00352.411.434.07            MEOHPIntercept−1.690.700.0347ln(creatinine)0.120.280.66541.130.612.10ln(MEOHP)−0.140.190.46780.870.571.32ln(lead)0.870.250.00492.391.384.12            MEPIntercept−2.250.480.0007ln(creatinine)0.000.200.99751.000.641.55ln(MEP)0.030.100.75801.030.831.29ln(lead)0.860.250.00612.361.354.11[Table B1](#t0040){ref-type="table"}, [Table B2](#t0045){ref-type="table"}, [Table B3](#t0050){ref-type="table"}, [Table B4](#t0055){ref-type="table"}, [Table B5](#t0060){ref-type="table"}, [Table B6](#t0065){ref-type="table"}

C. Summary of multiple logistic regression results -- weighted for all children {#s0025}
===============================================================================

See Table C1Summary of Multiple Logistic Regression Results for Parent or Self-Reported Outcomes from the Canadian Health Measures Survey Cycle 1 (Weighted) for All Children.Table C1**ADD/ADHDLearning disabilityMedicine takenContaminantAges 6--19 yrs OR (95% CI)ContaminantAges 6--19 yrs OR (95% CI)ContaminantAges 6--19 yrs OR (95% CI)BPA**1.29 (0.86--1.94)**BPA**1.09 (0.76--1.57)**BPA**M: 1.87 (1.24--2.83)F: 0.97 (0.72--1.31)[a](#tblC1fna){ref-type="table-fn"}**MBP**0.81 (0.55--1.20)**MBP**0.79 (0.56--1.13)**MBP**0.98 (0.60-1.60)            **MBzP**1.48 (0.93--2.36)**MBzP**1.24 (0.87--1.77)**MBzP**M: 1.54 (1.07--2.23)F: 0.78 (0.54--1.13)[a](#tblC1fna){ref-type="table-fn"}            **MCPP**0.98 (0.72--1.34)**MCPP**M: 0.89 (0.65--1.21)**MCPP**FS: 1.00 (0.69-1.44)F: 1.18 (0.86--1.62)[a](#tblC1fna){ref-type="table-fn"}NFS: 1.66 (1.15-2.40)[a](#tblC1fna){ref-type="table-fn"}**MEHHP**0.71 (0.42.1.20)**MEHHP**0.76 (0.44--1.31)**MEHHP**1.09 (0.56--2.10)**MEHP**0.85 (0.62--1.17)**MEHP**0.85 (0.59--1.21)**MEHP**1.01 (0.50--2.05)**MEOHP**0.71 (0.41--1.22)**MEOHP**0.76 (0.43--1.35)**MEOHP**1.09 (0.56--2.13)**MEP**0.75 (0.45--1.24)**MEP**0.79 (0.54--1.15)**MEP**1.17 (0.88--1.54)            **Blood lead**2.39 (1.32--4.32)**Blood lead**LI: 0.81 (0.37--1.81)**Blood lead**FS: 0.83 (0.34--2.02)HI: 2.78 (1.40--5.51)[a](#tblC1fna){ref-type="table-fn"}NFS: 4.20 (1.92--9.17)[a](#tblC1fna){ref-type="table-fn"}[^12]Table C2Summary of multiple regression results for SDQ outcomes from the Canadian health measures survey cycle 1 (weighted) for all children 6--17 years.Table C2**SDQ: Total difficultiesSDQ: Emotional symptomsSDQ: Hyperactivity/inattentionContaminantAges 6--17 yrs OR (95% CI)ContaminantAges 6--17 yrs OR (95% CI)ContaminantAges 6--17 yrs OR (95% CI)BPA**1.14 (0.96--1.36)**BPA**1.07 (0.97--1.19)**BPA**ETS: 0.67 (0.46--1.00)NETS: 1.31 (1.18-1.46)[a](#tblC2fna){ref-type="table-fn"}**MBP**1.09 (0.62--1.91)**MBP**0.87 (0.61--1.24)**MBP**1.59 (0.94--2.71)**MBzP**1.37 (1.06--1.76)**MBzP**0.90 (0.75--1.07)**MBzP**1.17 (0.96--1.43)**MCPP**1.06 (0.68--1.66)**MCPP**0.94 (0.78--1.13)**MCPP**1.22 (0.97--1.53)**MEHHP**0.89 (0.60--1.33)**MEHHP**1.05 (0.83--1.33)**MEHHP**1.04 (0.88--1.23)**MEHP**0.86 (0.58--1.26)**MEHP**0.98 (0.80--1.21)**MEHP**0.95 (0.75--1.20)**MEOHP**0.87 (0.57--1.32)**MEOHP**1.06 (0.83--1.34)**MEOHP**1.02 (0.85--1.21)**MEP**1.03 (0.83--1.29)**MEP**1.01 (0.87--1.18)**MEP**0.94 (0.82--1.08)**Blood lead**2.16 (1.33--3.51)**Blood lead**1.08 (0.68--1.71)**Blood lead**2.33 (1.59--3.43)[^13][Table C1](#t0070){ref-type="table"}, [Table C2](#t0075){ref-type="table"}
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[^1]: NR -- Not reported due to unacceptable quality.

[^2]: Odds ratio calculated at average value of Child׳s age

[^3]: Odds ratio calculated at average value of ln(Lead)

[^4]: Odds ratio calculated at average value of ln(MCPP)

[^5]: Odds ratio calculated at average value of ln(BPA)

[^6]: Odds ratio calculated at average value of ln(Lead)

[^7]: Odds ratio calculated at average value of ln(MBzP)

[^8]: Odds ratio calculated at average value of ln(creatinine)

[^9]: Odds ratio calculated at average value of ln(MCPP)

[^10]: Odds ratio calculated at average value of ln(BPA)

[^11]: Odds ratio calculated at average value of ln(MBP)

[^12]: Interaction terms significant at 5% level between contaminant and other covariates. M: males; F: females; LI: low income; HI; higher income; FS: fasting sample; NFS: non-fasting sample; Models adjusted for covariates as determined by a stepwise multiple regression procedure.

[^13]: Interaction terms significant at 5% level between contaminant and other covariates. ETS: smoking in home; NETS: no smoking in home; Models adjusted for covariates as determined by a stepwise multiple regression procedure.
